Michael Paulzen, MD
- 6Articles
- 48.9KReads
- 2008–2020Active
- 23Collaborators
- 198Citations
About
Michael Paulzen, MD, has contributed to the field of psychiatry through six articles published between 2008 and 2020. His work focuses on therapeutic drug monitoring in psychopharmacology, including the optimization of antipsychotic treatment, the impact of kidney function on risperidone levels, and the influence of genetic polymorphisms such as CYP2D6 on medication metabolism. He has also explored pharmacokinetic differences related to smoking status, concentrations of antidepressants in plasma and cerebrospinal fluid, and toxic psychosis induced by hallucinogens. His research intersects clinical pharmacology, neurology, and patient care in conditions such as depression, addiction, and dementia.
Publications
Kidney Function and Serum Risperidone Concentrations
November 26, 2019
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
